GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr | ₹-784 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹4,561 Cr |
Mar2023 | ₹-528 Cr |
Mar2022 | ₹-333 Cr |
Mar2021 | ₹-675 Cr |
Mar2020 | ₹-784 Cr |
How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹4,561 Cr | Positive | |
Mar2023 | ₹-528 Cr | Negative | |
Mar2022 | ₹-333 Cr | Negative | |
Mar2021 | ₹-675 Cr | Negative | |
Mar2020 | ₹-784 Cr | - |
Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹57,337.4 Cr | 1.6% | -7.3% | 39.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 1.6% |
-7.3% |
39.2% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses